Free Trial
NASDAQ:YSB

YS Biopharma (YSB) Stock Price, News & Analysis

About YS Biopharma Stock (NASDAQ:YSB)

Key Stats

Today's Range
N/A
50-Day Range
$0.40
$6.82
52-Week Range
N/A
Volume
63,510 shs
Average Volume
172,401 shs
Market Capitalization
$344.32 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.25
Consensus Rating
Buy

Company Overview

YS Biopharma Co., Ltd., a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer. The company develops a proprietary PIKA immunomodulating technology platform and a series of product targeting PIKA rabies vaccine, PIKA recombinant COVID-19 vaccine, and PIKA YS-ON-001. It operates in China, the United States, Singapore, the United Arab Emirates, and the Philippines. The company was founded in 2002 and is based in Beijing, China.

Receive YSB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for YS Biopharma and its competitors with MarketBeat's FREE daily newsletter.

YSB Stock News Headlines

LakeShore Biopharma Co Ltd Ordinary Shares LSB
Tim Sykes’ Urgent Trade Alert: “Make this move now”
WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT about Trump or Biden dropping out of the race…
LSB LakeShore Biopharma Co., Ltd
See More Headlines

YSB Stock Analysis - Frequently Asked Questions

Shares of YSB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Company Calendar

Today
10/17/2024
Fiscal Year End
3/31/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:YSB
Fax
N/A
Employees
773
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$5.25
High Stock Price Target
$5.25
Low Stock Price Target
$5.25
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$560.76 million
Book Value
$1.14 per share

Miscellaneous

Free Float
N/A
Market Cap
$344.32 million
Optionable
Not Optionable
Beta
0.51
(Almost)  Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

This page (NASDAQ:YSB) was last updated on 10/18/2024 by MarketBeat.com Staff
From Our Partners